Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PHIO Phio Pharmaceuticals

休市中 08-16 16:00:00 EDT

2.98

+0.40

+15.50%

盘后2.95

-0.03-1.01%

18:53 EDT

最高3.10	最低2.50	成交量4.33万
今开2.50	昨收2.58	日振幅23.26%
总市值256.49万	流通市值163.24万	总股本86.07万
成交额12.27万	换手率7.90%	流通股本54.78万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PHIO","market":"US","secType":"STK","nameCN":"Phio Pharmaceuticals","latestPrice":2.98,"timestamp":1723838400000,"preClose":2.58,"halted":0,"volume":43261,"hourTrading":{"tag":"盘后","latestPrice":2.95,"preClose":2.98,"latestTime":"18:53 EDT","volume":1517,"amount":4483.92,"timestamp":1723848810675},"delay":0,"floatShares":547800,"shares":860721,"eps":-28.686651,"marketStatus":"休市中","marketStatusCode":7,"change":0.4,"latestTime":"08-16 16:00:00 EDT","open":2.5,"high":3.1,"low":2.5,"amount":122703.33735,"amplitude":0.232558,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-28.686651,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724054400000},"adr":0,"adjPreClose":2.58,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":2.95,"preClose":2.98,"latestTime":"18:53 EDT","volume":1517,"amount":4483.92,"timestamp":1723848810675},"volumeRatio":1.0895769721901196,"impliedVol":2.2675,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/PHIO/wiki","defaultTab":"wiki","newsList":[{"id":"2460249971","title":"Phio Pharmaceuticals Corp.盘中异动 临近午盘股价大涨10.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460249971","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460249971?lang=zh_cn&edition=full","pubTime":"2024-08-16 23:54","pubTimestamp":1723823689,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日23时54分，Phio Pharmaceuticals Corp.股票出现异动，股价快速上涨10.47%。截至发稿，该股报2.85美元/股，成交量5327股，换手率1.04%，振幅7.36%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.17%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081623544997198fb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081623544997198fb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2459647783","title":"Phio Pharmaceuticals Corp.盘中异动 股价大跌7.00%报2.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459647783","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459647783?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:43","pubTimestamp":1723736634,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时43分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅下挫7.00%。截至发稿，该股报2.44美元/股，成交量2761股，换手率0.54%，振幅3.44%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为1.04%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815234354a1d4753b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815234354a1d4753b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2459180665","title":"Phio Pharmaceuticals Corp.盘中异动 股价大跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459180665","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459180665?lang=zh_cn&edition=full","pubTime":"2024-08-14 01:40","pubTimestamp":1723570855,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日01时40分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅下跌5.38%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为2.10%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814014055af9744d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814014055af9744d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2458398509","title":"Phio Pharmaceuticals Corp.盘中异动 急速拉升6.56%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458398509","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458398509?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:38","pubTimestamp":1723469881,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时38分，Phio Pharmaceuticals Corp.股票出现波动，股价快速拉升6.56%。截至发稿，该股报2.60美元/股，成交量1080股，换手率0.21%，振幅0.00%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.57%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122138019f2492f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122138019f2492f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2458554898","title":"Phio Pharmaceuticals Corp.盘中异动 大幅下跌5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458554898","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458554898?lang=zh_cn&edition=full","pubTime":"2024-08-10 03:01","pubTimestamp":1723230067,"startTime":"0","endTime":"0","summary":"北京时间2024年08月10日03时01分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅跳水5.70%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为2.44%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810030107941ffc8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810030107941ffc8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2457311028","title":"Phio Pharmaceuticals Corp.盘中异动 早盘大幅跳水12.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457311028","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457311028?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:50","pubTimestamp":1723125025,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日21时50分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅跳水12.34%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为1.98%。其相关个股中，Conduit Pharmaceuticals Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Oragenics Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Oragenics Inc.较为活跃，换手率分别为241.57%、233.39%、114.60%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Entero Therapeutics Inc.，振幅分别为57.58%、40.44%、35.28%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808215026941ff767&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808215026941ff767&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2457842591","title":"Phio Pharmaceuticals Corp.盘中异动 股价大涨9.73%报3.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457842591","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457842591?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:57","pubTimestamp":1723039028,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时57分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅上涨9.73%。截至发稿，该股报3.09美元/股，成交量1035股，换手率0.20%，振幅1.06%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为1.31%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807215708af9669b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807215708af9669b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2457026146","title":"Phio Pharmaceuticals Corp.盘中异动 早盘大幅拉升6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457026146","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457026146?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:15","pubTimestamp":1722953700,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日22时15分，Phio Pharmaceuticals Corp.股票出现波动，股价急速上涨6.14%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为1.50%。其相关个股中，Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Alpha Tau Medical Ltd C/Wts 涨幅较大，Tenax Therapeutics, Inc.、Vbi Vaccines, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1094.34%、913.33%、283.40%，振幅较大的相关个股有Vbi Vaccines, Inc.、Actinium Pharmaceuticals, Inc. 、Scorpius Holdings, Inc.，振幅分别为168.52%、43.54%、42.16%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408062215009582e097&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408062215009582e097&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2457482240","title":"Phio Pharmaceuticals Corp    预计每股亏损 4.59 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457482240","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457482240?lang=zh_cn&edition=full","pubTime":"2024-08-06 19:38","pubTimestamp":1722944296,"startTime":"0","endTime":"0","summary":"   * Phio Pharmaceuticals Corp    预计将于8月8日公布截至2024年6月30日的财报(预计)    *    * LSEG 的分析师平均预计 Phio Pharmaceuticals Corp 每股亏损 4.59 美元。* 分析师对该公司股票的评级为 \"买入\"。* 生物技术与医学研究同行的平均一致建议也是 \"买入\"。* 华尔街对 Phio Pharmaceuticals Corp 的 12 个月目标价中位数为 36.00 美元，高于上一交易日的收盘价 2.77 美元。8月6日 - 本摘要于北京时间 8 月 6 日 11:38 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Phio Pharmaceuticals Corp    预计每股亏损 4.59 美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO"],"gpt_icon":0},{"id":"2457737627","title":"Phio Pharmaceuticals Corp.盘中异动 股价大跌5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457737627","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457737627?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:37","pubTimestamp":1722865047,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时37分，Phio Pharmaceuticals Corp.股票出现异动，股价快速下跌5.58%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为1.83%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213727aefd4c86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213727aefd4c86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2456431176","title":"Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456431176","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456431176?lang=zh_cn&edition=full","pubTime":"2024-08-01 22:42","pubTimestamp":1722523344,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日22时42分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅下挫5.59%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Biomea Fusion, Inc.、Immuneering Corporation涨幅较大，Windtree Therapeutics, Inc.、Immuneering Corporation、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为275.28%、189.16%、90.95%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Biomea Fusion, Inc.，振幅分别为40.35%、37.21%、36.00%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801224224af95638b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801224224af95638b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2456489555","title":"Phio Pharmaceuticals - 任命Robert m. Infarinato为副总裁兼财务总监任职时间为2024年8月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=2456489555","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456489555?lang=zh_cn&edition=full","pubTime":"2024-08-01 20:12","pubTimestamp":1722514343,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2455137539","title":"Phio Pharmaceuticals Corp.盘中异动 大幅跳水5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455137539","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455137539?lang=zh_cn&edition=full","pubTime":"2024-07-31 22:07","pubTimestamp":1722434871,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日22时07分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅下跌5.67%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.69%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731220751968224b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731220751968224b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2455517959","title":"Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.16%报3.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455517959","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455517959?lang=zh_cn&edition=full","pubTime":"2024-07-30 22:54","pubTimestamp":1722351247,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日22时54分，Phio Pharmaceuticals Corp.股票出现波动，股价快速下挫5.16%。截至发稿，该股报3.31美元/股，成交量5257股，换手率1.03%，振幅3.72%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.25%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730225407af94de00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730225407af94de00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2455680586","title":"Phio Pharmaceuticals Corp.盘中异动 股价大跌7.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455680586","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455680586?lang=zh_cn&edition=full","pubTime":"2024-07-29 21:31","pubTimestamp":1722259878,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日21时31分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅下挫7.65%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.02%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072921311896821345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072921311896821345&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2454234473","title":"Phio Pharmaceuticals Corp.盘中异动 早盘急速下跌7.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454234473","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454234473?lang=zh_cn&edition=full","pubTime":"2024-07-26 22:12","pubTimestamp":1722003174,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日22时12分，Phio Pharmaceuticals Corp.股票出现波动，股价快速下挫7.71%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Windtree Therapeutics, Inc.、Nutriband Inc C/Wts 、Sangamo Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.、Cel-Sci Corporation较为活跃，换手率分别为4662.30%、143.52%、80.61%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Sangamo Therapeutics, Inc.、Cel-Sci Corporation，振幅分别为73.86%、66.22%、60.32%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072622125596820d2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072622125596820d2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2454877329","title":"Phio Pharmaceuticals Corp.盘中异动 股价大涨12.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454877329","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454877329?lang=zh_cn&edition=full","pubTime":"2024-07-25 22:18","pubTimestamp":1721917080,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日22时18分，Phio Pharmaceuticals Corp.股票出现异动，股价急速拉升12.50%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.96%。其相关个股中，Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Azitra Inc较为活跃，换手率分别为2077.38%、414.45%、162.64%，振幅较大的相关个股有Psyence Biomedical Ltd.、Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为114.90%、98.60%、82.05%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725221800941faa33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725221800941faa33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2453888462","title":"Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.54%报3.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453888462","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453888462?lang=zh_cn&edition=full","pubTime":"2024-07-24 21:45","pubTimestamp":1721828756,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日21时45分，Phio Pharmaceuticals Corp.股票出现异动，股价急速跳水5.54%。截至发稿，该股报3.56美元/股，成交量7629股，换手率1.50%，振幅4.77%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.01%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407242145569681fd95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407242145569681fd95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2453412030","title":"Phio Pharmaceuticals Corp.盘中异动 早盘大幅拉升5.23%报4.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453412030","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453412030?lang=zh_cn&edition=full","pubTime":"2024-07-23 21:35","pubTimestamp":1721741752,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日21时35分，Phio Pharmaceuticals Corp.股票出现波动，股价急速上涨5.23%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Azitra Inc、Adial Pharmaceuticals, Inc、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Azitra Inc、Adial Pharmaceuticals, Inc、Jaguar Health, Inc.较为活跃，换手率分别为1555.93%、845.41%、63.84%，振幅较大的相关个股有Azitra Inc、Adial Pharmaceuticals, Inc、Biomx Inc.，振幅分别为192.59%、61.32%、11.06%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723213553aefb020a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723213553aefb020a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2453794749","title":"Phio Pharmaceuticals Corp.盘中异动 早盘急速跳水8.00%报4.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453794749","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453794749?lang=zh_cn&edition=full","pubTime":"2024-07-22 23:15","pubTimestamp":1721661336,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日23时15分，Phio Pharmaceuticals Corp.股票出现波动，股价快速跳水8.00%。截至发稿，该股报4.14美元/股，成交量5529股，换手率1.08%，振幅4.44%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.57%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722231536941f9342&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722231536941f9342&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.phiopharma.com","stockEarnings":[{"period":"1week","weight":0.2213},{"period":"1month","weight":-0.3682},{"period":"3month","weight":-0.5792},{"period":"6month","weight":-0.4983},{"period":"1year","weight":-0.8548},{"period":"ytd","weight":-0.5643}],"compareEarnings":[{"period":"1week","weight":0.04},{"period":"1month","weight":-0.0047},{"period":"3month","weight":0.047},{"period":"6month","weight":0.1097},{"period":"1year","weight":0.2705},{"period":"ytd","weight":0.1662}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Phio Pharmaceuticals Corp.是一家生物技术公司，基于公司专有的新一代核糖核酸干扰(RNAi)平台专注于发现、开发和商业化创新疗法。由于这些疗法得“沉默”能力,或者说是其下调能力,病态情况下的特定基因可以被分析的更为清楚，所以基于RNAi平台的疗法更有说服力的。2011年9月8日之前,该公司的业务由其非操作部门Galena Biopharma公司（该公司的前母公司）来完成。公司成立于特拉华州，作为Galena 的全资子公司。2011年9月8日开始，其计划并准备与Galena脱离。2012年4月27日这一计划得以完成。至此之后,公司作为一个独立的上市公司运营。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.062312},{"month":2,"riseRate":0.4,"avgChangeRate":-0.033019},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.080586},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.121062},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.038426},{"month":6,"riseRate":0.454545,"avgChangeRate":-0.020605},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.103097},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.0228},{"month":9,"riseRate":0,"avgChangeRate":-0.17163},{"month":10,"riseRate":0.3,"avgChangeRate":-0.130613},{"month":11,"riseRate":0.4,"avgChangeRate":-0.060945},{"month":12,"riseRate":0.2,"avgChangeRate":-0.125431}],"exchange":"NASDAQ","name":"Phio Pharmaceuticals","nameEN":"Phio Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Phio Pharmaceuticals(PHIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Phio Pharmaceuticals,PHIO,Phio Pharmaceuticals股票,Phio Pharmaceuticals股票老虎,Phio Pharmaceuticals股票老虎国际,Phio Pharmaceuticals行情,Phio Pharmaceuticals股票行情,Phio Pharmaceuticals股价,Phio Pharmaceuticals股市,Phio Pharmaceuticals股票价格,Phio Pharmaceuticals股票交易,Phio Pharmaceuticals股票购买,Phio Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Phio Pharmaceuticals(PHIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}